InvestorsHub Logo
Followers 200
Posts 9988
Boards Moderated 0
Alias Born 06/14/2006

Re: Palmeiras91 post# 31864

Wednesday, 01/15/2020 4:20:39 PM

Wednesday, January 15, 2020 4:20:39 PM

Post# of 52127
Yep. Told them at info@oraltabs.com I wanted to be first in line. Lol.

"The Company has finalized and executed a definitive agreement with Symtomax, a leading licensed cannabis cultivation company with the largest outdoor grow facilities in Europe. Symtomax has a number of agreements in place with European government health ministries to manufacture and distribute cannabidiol products through their health systems. Pending finalization of regulatory approvals, we expect this to start yielding revenue in the form of royalty payments for Greater Cannabis in year one of commercialization based on current timing projections. Further opportunities in Africa are being explored in parallel."

To me year one starts the day oraltabs.com goes live and the first product is sold. IMO they most likely have already received some royalty payments if production has already started.

"The company has been exploring options for large scale manufacturing. Our current manufacturing capabilities are limited to less than 10,000 units per month through our small-scale manufacturing facility and R&D lab in New Jersey. We have successfully identified and aligned ourselves with two contract manufacturing organizations (CMOs). These two companies have decades of experience with manufacturing our dosage forms for Rx products, and our team has worked with them in the past. They offer us cGMP manufacturing capabilities with the ability to produce millions of units per month. This is a critical milestone for the Company to be able to achieve market penetration through our partners’ distribution channels. For partner companies needing a THC product, we have aligned ourselves with two companies that manufacture the machinery required to produce our delivery system in our partners’ facilities as opposed to in our CMOs facilities. We believe with these two options available we can now advance our commercialization strategy and begin to take products out of the lab and into the hands of consumers.'

https://www.otcmarkets.com/stock/GCAN/news/The-Greater-Cannabis-Company-Provides-Corporate-Update-to-Shareholders?id=240905

Pretty sure they are talking Symtomax here.

CBD retail is dead. Find something better. JMHO.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GCAN News